BIOTHERAPIES INC has a total of 17 patent applications. Its first patent ever was published in 1997. It filed its patents most often in Australia, Brazil and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and biotechnology are HALE GEOFFREY, PROTHERICS PLC and KARYON OY.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 2 | |
#2 | Brazil | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Israel | 2 | |
#5 | United States | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | Canada | 1 | |
#8 | China | 1 | |
#9 | Mexico | 1 | |
#10 | New Zealand | 1 | |
#11 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Ervin Paul R Jr | 10 |
#2 | Ervin Paul R | 1 |
#3 | Ervin Jr Paul R | 1 |
#4 | Ervin P R Jr | 1 |
#5 | Ervin Paul R Jr. | 1 |
#6 | Ervin Raul R Jr | 1 |
Publication | Filing date | Title |
---|---|---|
US6939714B2 | Epithelial cell growth inhibitors | |
BR0012301A | Epithelial cell growth inhibitors | |
BR9713248A | Sequence of nucleotides and mamstatin proteins and processes of use | |
IL129241D0 | Nucleotide and protein sequence of mammastatin and methods of use |